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Abstract
Background: Argonaute, the core component of the RNA induced silencing complex (RISC), binds to mature
miRNAs and regulates gene expression at transcriptional or post-transcriptional level. We recently reported that
Argonaute 2 (Ago2) also assembles into complexes with miRNA precursors (pre-miRNAs). These Ago2:pre-miRNA
complexes are catalytically active in vitro and constitute non-canonical RISCs.
Results: The use of pre-miRNAs as guides by Ago2 bypasses Dicer activity and complicates in vitro RISC
reconstitution. In this work, we characterized Ago2:pre-miRNA complexes and identified RNAs that are targeted by
miRNAs but not their corresponding pre-miRNAs. Using these target RNAs we were able to recapitulate in vitro
pre-miRNA processing and canonical RISC loading, and define the minimal factors required for these processes.
Conclusions: Our results indicate that Ago2 and Dicer are sufficient for processing and loading of miRNAs into
RISC. Furthermore, our studies suggest that Ago2 binds primarily to the 5’- and alternatively, to the 3’-end of select
pre-miRNAs.
Background
MicroRNAs (miRNAs) are small (~22 nucleotide) non-
coding RNAs that associate with Argonaute proteins in
ribonucleoprotein complexes (miRNPs or RISCs) [1-5].
MicroRNAs play diverse regulatory roles in development
and physiological cellular functions [6-8]. In addition,
miRNAs are involved in a wide spectrum of human dis-
eases including cancer, cardiovascular and autoimmune
inflammatory conditions [8-14].
Post-transcriptional nuclear processing of primary
miRNA transcripts (pri-miRNAs) by the RNAse III
enzyme Drosha and its RNA-binding partner, DiGeorge
syndrome Critical Region gene 8 protein (DGCR8)
[15-18], generates ~ 65-75 nucleotide (nt) hairpin-struc-
tured miRNA precursors (pre-miRNAs). Pre-miRNAs
are subsequently bound to the RAN-GTP protein
Exportin-5 and are transported to the cytoplasm [19-22]
where they undergo processing by the RNAse III
enzyme Dicer into ~ 22 nt RNA duplexes [23,24]. TAR
RNA binding protein (TRBP) facilitates Dicer processing
of pre-miRNAs [25-28]. Ago proteins act as RNA cha-
perones facilitating unwinding of RNA duplexes and
loading of single-stranded miRNAs into Ago complexes
[29,30]. The mechanisms involved in miRNA strand
selection in mammals are poorly understood.
We previously reported that endogenous Ago2-pre-
miRNA (pre-miRNPs) complexes are detected in cyto-
plasmic and nuclear extracts of human cells, and that
pre-miRNPs are enriched in Dicer-null cells [31]. We
showed that recombinant pre-miRNPs function as
RISCs in vitro. This finding complicated our in vitro
RISC reconstitution studies since recombinant Ago2 in
complex with pre-miRNAs cleaves target RNAs bypass-
ing the requirement for Dicer activity. In this study, we
identified RNA targets that are not cleaved by Ago2:pre-
miRNA complexes. We demonstrated that Dicer and
Ago2 are sufficient for in vitro recapitulation of the
cytoplasmic miRNP assembly and that TRBP is dispen-
sable. We also showed that select Ago2:pre-miRNA
complexes are active against 5’-as well as 3’-arm RNA
targets, suggesting that Ago2 binds primarily to the 5’-
and alternatively, to the 3’-end of select pre-miRNAs.
Results
Recombinant Ago2:pre-miR-24-1 complex directs
cleavage of a 5’- but not of a 3’-arm target
We previously reported that mammalian Ago2 directly
binds to pre-miRNAs and forms active, non-canonical,
RISC (pre-miRNPs) in vitro [31]. Ago2 can only use the
hairpin-like pre-miRNAs as guides for target cleavage
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when spontaneous or Ago2-mediated dissociation of the
hairpin arms permits target annealing to pre-miRNAs.
Interestingly, two recent studies demonstrated RNA
chaperone activity of human Ago proteins against RNA
duplexes [29,30].
Although the function and biological significance of
endogenous pre-miRNPs is unclear, non-canonical RISC
activity of pre-miRNPs complicates studies of RISC
reconstitution. To bypass this alternative in vitro path-
way, we first asked whether non-canonical RISC is also
active against targets complementary to the 3’-arm of
pre-miRNAs.
To test our hypothesis, we preloaded purified GST-
Ago2 with pre-miR-24-1 in near stoichiometric amounts
and added a 5’-P32-radiolabeled target complementary
to either the 5’- or the 3’-arm of pre-miR-24-1. As
expected, efficient 5’-arm target cleavage was detected in
the absence of Dicer, whereas 3’-arm target cleavage was
not observed (Figure 1). This suggests preferential activ-
ity of pre-miR-24-1:Ago2 complex against targets com-
plementary to the proximal end of pre-miR-24-1.
Ago2 and Dicer are sufficient for in vitro recapitulation of
cytoplasmic steps of miRNA biogenesis
Although in vitro reconstitution of mammalian RISC
with recombinant Ago2, Dicer and TRBP has been pre-
viously reported, it is unclear whether in this study
RISC was formed by Ago loaded with a Dicer-generated
miRNA or unprocessed pre-miRNA [32]. Having
demonstrated inactivity of Ago2-pre-miR-24-1 against a
3’-arm target, we were in a position to test RISC load-
ing, by circumventing the non-canonical pathway. Ago2
was incubated with 5’-P-pre-miR-24-1 and Dicer, but
not TRBP, then provided with a 5’-radiolabeled 3’-arm
RNA target (Ta-3). Reaction products were analyzed by
Urea-PAGE. Efficient cleavage of the radiolabeled Ta-3
was observed (Figure 2A), indicating TRBP-independent
loading of the 3’-arm product of pre-miR-24-1 into
Ago2. Inclusion of TRBP to the reconstitution reactions
did not affect RISC activity (Figure 2A). These results
indicate that Ago2 and Dicer alone were sufficient for
canonical RISC loading in vitro.
In order to demonstrate that the 5’-arm product of
pre-miR-24-1 was also loaded into Ago2, in addition to
the 3’-arm product, the same reactions were repeated
using 5’-radiolabeled pre-miR-24-1 and unlabeled RNA
target. Labeled RNAs were analyzed by denaturing and
native PAGE (Figure 2B and 2C). As expected, Dicer,
but not Ago2 or TRBP, processed pre-miR-24-1 to ~21
nucleotide miR-24-1:miR-24-1* duplex, which was then
dissociated by Ago2 and formed canonical RISC loaded
with either miR-24-1 or miR-24-1* (Figure 2C and 2A).
Although when these reactions were repeated with
labeled pre-miR-24-1 and unlabeled target RNA, TRBP
appeared to have a mild inhibitory effect on Dicer (Fig-
ure 2B), such effect was not observed when pre-miR-30
was used instead of pre-miR-24-1 (Additional File 1) or
when RISC activity was tested (Figure 2A). Irrespective
of regulatory activity, the presence of TRBP was also
not essential for pre-miR-30a RISC loading reconstitu-
tion (Additional File 1). Together, our results indicate
that recombinant Ago2 and Dicer are sufficient to reca-
pitulate RISC assembly in vitro. We demonstrated
unwinding of Dicer-generated miRNA duplexes in the
presence of Ago2 and RISC loading with single-stranded
miRNAs deriving either from the 3’-arm (as indicated
by RISC activity shown in Figure 2A and Additional File
1A), or the 5’- arm of pre-miR-24-1 (as shown in Figure
2B and 2C and Additional File 1B and 1C). TRBP is not
essential for pre-miRNA processing by Dicer, unwinding
of the RNA duplex or loading of miRNA or miRNA*
into Ago2.
RISC activity of select pre-miRNPs is guided against 5’-
and 3’-arm targets
We tested several pre-miRNAs to demonstrate that a
non-canonical Dicer-free Ago pre-miRNP is preferen-
tially active against a 5’-arm target. Surprisingly, we
observed 3’-arm target cleavage by select pre-miRNA-
guided RISCs. Pre-miR-24-1 and pre-miR-30a consis-
tently demonstrated 5’- but not 3’-arm target cleavage,
while pre-miR-138-2 and pre-miR-103-2 guided cleavage
of targets complementary to both arms. In the case of
pre-miR-138-2, the 17nt 5’- cleavage product of target
Tb-5 (complementary to the 5’-arm of pre-miR-138-2),
corresponds, as expected, to cleavage across the nucleo-
tide in position 10 from the 5’-end of pre-miR-138-2
(Figure 3A). The 5’- product of the 3’-arm target Tb-3
(16 nt) corresponds to cleavage across the nucleotide in
position 10 from the 3’-end of pre-miR-138-2 (Figure
3A). An additional 18nt 5’-product is seen, indicating
cleavage across position 12 from the 3’-end. These find-
ings suggest that, in vitro, in addition to binding to the
5’-phosphorylated end, recombinant Ago2 likely binds
to the 3’-unphosphorylated end of pre-miR-138-2.
Imprecise cleavage of the 3’-arm target resulting in two
different size products suggests weak Ago2 binding to
the unphosphorylated base of the 3’-end. An alternative
explanation of these findings would be that Ago2 pro-
cesses pre-miRNAs and is then loaded with guide RNAs
deriving from their 3’- arm. However, we have pre-
viously [31] and currently demonstrated that such pro-
cessing is not detected in vitro (Figure 2B and
Additional File 1B) at least with the conditions and pre-
miRNAs we tested using purified, Dicer-free, recombi-
nant Ago2, ruling out this alternative scenario.
Pre-miR-103-2, like pre-miR-138-2, directed cleavage
of targets complementary to its 5’- and 3’- arms
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(Additional File 2). Imprecise cleavage of the 3’-arm tar-
get was noted again, as with pre-miR-138-2. In pre-miR-
103-2-guided cleavage, addition of recombinant TRBP
was not crucial for the use of the 5’- or 3’- pre-miRNA
arm by Ago2 (Additional File 2).
When Ago2 was loaded with a 73-nucleotide single-
stranded, unstructured RNA, both 5’- and 3’- end tar-
gets were cleaved, although 3’-end target cleavage was
significantly less efficient (Figure 3B, and Additional File
3 for guide:target RNA alignment). This again suggests
that Ago2 binds primarily, as expected, to the 5’-phos-
phorylated base of the guide RNA and can also bind to
a small extent to the 3’- unphosphorylated base of the
single-stranded guide RNA.
Endogenous Ago2-pre-miRNA complexes are detected
in nuclear and cytoplasmic extracts of mammalian cells
[31]. We have previously shown that in Dicer-null
mouse embryonic fibroblasts (MEFs), endogenous Agos
Figure 1 Recombinant Ago2:5’P -pre-miR-24-1 complex is active against a 5’- but not a 3’-arm target. Cleavage assay results of
recombinant Ago2 pre-incubated with 5’-P-pre-miR-24-1 before the addition of radiolabeled 5’-arm (Ta-5) or 3’-arm (Ta-3) target. Predicted sizes
of 5’-end cleavage products of 5’- and 3’-arm targets are 17nt and 14nt respectively. Radiolabeled pBR322/MspI (M) was used as size marker.
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are loaded with unprocessed pre-miRNAs [31]. To test
whether Ago2 binds to the 3’- end of endogenous pre-
miRNAs, we immunoprecipitated Ago complexes from
Dicer-/- MEFs using the 2A8 antibody[33] and per-
formed in vitro RISC assays. In this inducible cell line a
small amount of let-7a is detected (Figure 4B and[31])
even when Dicer is undetectable (Additional File 4).
However, let-7a*, which normally originates from the 3’-
arm of pre-let-7a, is not detected in total RNA from
Dicer +/- or Dicer-/- MEFs (Figure 4C). To test the RISC
activity of endogenous pre-let7-a RNPs, we provided
RNA targets complementary to the 5’- and 3’-arm of
pre-let-7a. In addition to the 5’- arm cleavage, a 3’-arm
target cleavage product was observed, likely generated
by RISC activity of pre-let-7a RNPs, rather than by
canonical, let-7a* miRNPs (Figure 4A), suggesting that
endogenous pre-let-7a associates to Ago2 via either its
5’-phosphorylated or its 3’- unphosphorylated end.
Discussion
Most endogenous pre-miRNAs are normally processed
by Dicer and consequently functional miRNPs are more
abundant than pre-miRNPs [31]. We have previously
shown that canonical pre-miRNAs associate with Ago2
and that in vitro, Dicer-free Ago2 does not process pre-
miRNAs into mature miRNAs or any intermediate pro-
ducts [31]. It was subsequently shown that Ago2 binds
to pre-miR-451 and mediates its processing via a non-
canonical, Dicer-independent pathway [34,35]. Unlike
most mammalian miRNAs, pre-miR-451 has a unique
Figure 2 Recombinant Ago2 and Dicer are sufficient to recapitulate processing of 5’P -pre-miR- 24-1 and loading of miR-24-1* strand
into Ago2 in vitro. A. Results of cleavage assays using recombinant Ago2, Dicer, and TRBP (in combinations as indicated) pre-incubated with 5’
-P-pre-miR-24-1, prior to the addition of radiolabeled 3’ -arm target (Ta-3). B. Experiments were performed as in (A), except with radiolabeled
pre-miR-24-1 and unlabeled 3’ -arm target (Ta-3). 50% of the total volume of each reaction was analyzed on 15% Urea PAGE and RNAs were
detected by autoradiography. C. The remaining 50% of each reaction was analyzed by native RNA gel electrophoresis. Pre-annealed 22nt RNA
duplex was used as size marker.
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Figure 3 Recombinant Ago2: pre-miR-138-2 and Ago2:73nt ssRNA complexes direct 5’ - and 3’ -arm target cleavage. A. Results of
cleavage assay with recombinant Ago2 pre-incubated with gel-extracted 5’ -P-pre-miR-138-2, before the addition of radiolabeled gel-purified
RNA targets complementary to its 5’ - (Tb-5) or 3’ -arm (Tb-3). Predicted size of 5’ - cleavage product of Tb-5 and Tb-3 is 17 nt and 16 nt
respectively. B. Experiments were performed as in (A), except that a gel-purified 73nt single-stranded (ss) RNA was pre-incubated with Ago2
before the addition of radiolabeled 5’ -end (Tc-5) or 3’ -end target (Tc-3). Predicted sizes of 5’ - end cleavage products of 5’ -arm and 3’ -arm
targets are 60 nt and 15 nt respectively.
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Figure 4 Endogenous pre-Let7a-3:Ago2 complexes guide 5’- and 3’- arm target cleavage in vitro. A. Endogenous pre-miRNPs were
immunopurified using anti-Ago (2A8) antibody or from Dicer+/- or Dicer-/- mouse embryonic fibroblasts (MEFs). Non-immune mouse serum (NMS)
was used as control. 30% of the total volume of agarose G beads from each immunoprecipitation (IP) was then incubated either with
radiolabeled 5’ -arm (Td-5) or with 3’ -arm target (Td-3) and then treated with proteinase K. Predicted size of 5 -cleavage product of 5’ -arm and
3’ -arm target is 9 nt and 16 nt respectively. B and C. Expression of let-7a or let-7a * was detected by Northern blot of total RNA (20 μg/lane)
isolated from Dicer+/- or Dicer-/- MEFs, using DNA antisense probes. For loading control, let-7a and let-7a * expression was normalized against the
expression of U6 RNA.
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stem structure, with a perfect sense:antisense comple-
mentarity, resembling a 17nt siRNA duplex. Our present
and previous studies [31] indicate that pre-miRNAs with
stem bulges are not processed by Ago2, but are used as
guides for RISC activity in vitro. Our unexpected find-
ings, also reported by Yoda et al [30], complicate in
vitro dissection of RISC biogenesis and function.
In this study, we identified pre-miRNPs inactive
against 3’-arm targets and this finding allowed us to
demonstrate that Dicer and Ago2 are sufficient to pro-
cess pre-miRNAs, unwind miRNA duplexes and load
single-stranded miRNAs into Ago2. TRBP was dispensa-
ble for all three steps in vitro, arguing against an essen-
tial role for this protein in RISC reconstitution or
miRNA strand selection but not excluding a regulatory
function. Several studies have shown regulation of
miRNA biogenesis by auxiliary factors (Reviewed in
[36]). It has been previously shown that TRBP regulates
pre-miRNA processing by Dicer [25-28]; furthermore, it
has been proposed that TRBP is necessary to recruit
Ago2 to the Dicer/substrate complexes [37]. Earlier
reports suggested that TRBP in complex with Ago and
Dicer is required for RISC loading reconstitution in
vitro [32]. Our studies indicate that TRBP is not essen-
tial for this process.
Apart from clarifying the minimal factors required for
mammalian RISC loading, our results suggest that pre-
miRNAs bind to Ago2 via either their 5’- or 3’- end.
Crystal structure studies have shown that the 3’- [38,39]
and the 5’- end [40] of miRNAs bind to Argonaute pro-
teins and that there is a strong preference for U or A as
a first 5’- end base [41,42]. It is likely that pre-miRNAs
are anchored within Ago2 in a similar fashion. We
tested four differently structured pre-miRNAs and the
size of the 5’-arm target product consistently corre-
sponded to the expected cleavage across the nucleotide
in position 10 from the 5’-end of the pre-miRNA. Most
of the 3’-arm target products corresponded also to clea-
vage across the 10th nucleotide from the 3’-end. How-
ever, additional products were detected suggesting
imprecise cleavage, likely due to weak Ago2 binding to
the 3’-unphosphorylated pre-miRNA end. It is unlikely
that these RNA products represent degradation artifacts,
as all the radiolabeled RNA oligos were gel-purified.
Conclusions
Our results indicate that Ago2 and Dicer are sufficient
for processing and loading of miRNAs into RISC.
Furthermore, our studies suggest that Ago2 binds pri-
marily to the 5’-and alternatively, to the 3’-end of select
pre-miRNAs. Results from our experiments using
immunopurified pre-miRNPs from Dicer-null cells also
support this alternative mode of endogenous pre-
miRNA binding to Ago2. Endogenous pre-miRNPs
accumulate in Dicer-deficient cells, likely because the
secondary structure of pre-miRNAs and/or their binding
by Ago2 protects them from degradation; normally,
Ago2 containing pre-miRNPs are not abundant [31].
Since it is unlikely that miRNPs and pre-miRNPs exert
redundant regulatory functions on gene expression, our
in vitro findings should be cautiously interpreted, until
the function of pre-miRNPs and biological significance
of their RISC activity are elucidated.
Methods
Expression and Purification of GST-Ago2 and GST-TRBP
Recombinant GST-Ago2 and GST-tagged human
TRBP2 isoform a (NM_134323.1) were expressed using
the baculovirus protein expression system and purified
as described previously [31]. For protein purification,
the baculovirus-infected Sf9 cell pellets were sonicated
and recombinant protein was purified by Glutathione
sepharose beads, washed and further purified by anion
exchange chromatography. Silver nitrate gel analyses
and pre-miRNA processing assays were performed with
every protein batch to ensure purity of recombinant
Ago2 or TRBP and absence of Dicer (or Ago2 from
TRBP preparations) or other associating proteins. Wes-
tern Blot analyses with primary antibodies against Dicer
(Novus NBP1-06520, 1:2000), 2A8 ([33], 1:1000) and
TRBP ([25], 1:1000) were also performed (Additional
File 5).
5’- labeling of RNAs
RNA oligonucleotides were 5’-end radiolabeled with T4
polynucleotide kinase (NEB M0201S) as previously
described [43,44].
Cleavage and Reconstitution Assays
Cleavage assays were performed as previously described
[31]. For reconstitution assays, 20 ng recombinant GST-
Ago2, GST-TRBP and/or Dicer (Ambion AM2212) were
pre-incubated with 20 nM of 5’-P-pre-miRNA at 37°C
for 30 min. ~5 nmol of gel extracted, 5’- radiolabeled
RNA target was then added to the reactions, which
were then incubated at 37°C for additional 60 min. Clea-
vage products were then analyzed on 15% UREA PAGE.
A 5’ radiolabeled size marker (pBR322/MspI, NEB) was
used for size control and radiolabeled cleavage products
were detected by autoradiography. Nucleotide sequences
of synthetic RNAs are listed in Additional File 6.
To analyze pre-miRNAs and their products in recon-
stitution assays, 5’- 32P- pre-miR-30a (20 nM) or 5’-32P-
pre-miR-24-1, was incubated with 20 ng GST-Ago2,
GST-TRBP and/or Dicer at 37°C for 30 min before
addition of cold RNA targets for 60 min. 50 percent of
the reaction volume was analyzed on 15% UREA PAGE.
The remaining 50 percent was mixed with native RNA
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loading buffer (6% w/v Ficoll 400, 0.08% bromophenol
blue (w/v) and 4 mM Tris pH7.5) and analyzed on 0.75
mm 15% native polyacrylamide (19:1), 0.5X TBE gel at
125V (80-25 mA). Radiolabeled RNA products were
detected by autoradiography.
Dicer-null mouse embryonic fibroblasts (MEFs)
The inducible Dicer-null MEFs were immortalized, cul-
tured and induced as previously described [31].
Immunoprecipitations and Northern blot analyses
Dicer-null MEF lysates were incubated with 20 μL of
protein G agarose beads (Roche #11 243 233 001) pre-
bound to 2 μL of non-immune mouse serum or 20 μL
of anti-Ago 2A8 antibody [33] at 4°C overnight. Agarose
beads were then washed five times in lysis buffer (20
mM Tris pH7.5, 200 mM NaCl, 2.5 mM MgCl2 and
0.5% Triton X-100) containing protease inhibitors (BMB
#11697498001). 10 percent of total protein G agarose
volume was used for Western blot and 30 percent for
cleavage assay.
Northern blot analyses of total RNA isolated from
Dicer-null MEFs (miRVana, Ambion) were performed as
previously described [43,44]. 5’-32P- let-7a or let-7a*
DNA antisense probes were used to detect let-7a and
let-7a* expression. For loading control, miRNA expres-
sion was normalized against the expression of U6,
detected with a DNA antisense probe.
Additional material
Additional File 1: In vitro reconstitution of miR-30 miRNP.
Recombinant Ago2 and Dicer Pare sufficient to recapitulate processing of
5’P-pre-miR-30a and loading of miR-30a* into Ago2 in vitro.
Additional File 2: In vitro RISC activity of pre-miR-103-2 miRNP. Pre-
miR-103-2 directs 5’ -and 3’ - arm target cleavage.
Additional File 3: Unstructured, single stranded RNA and targets.
Sequence of 73nt single stranded RNA aligned to the sequences of the
5’ - and 3’ -end targets.
Additional File 4: Dicer Western Blot. Dicer detection in Dicer+/- and
Dicer-/- MEFs.
Additional File 5: Purified recombinant Ago2, TRBP and Dicer. Silver
stain and Western Blot.
Additional File 6: Synthetic RNAs and DNA probes. Sequences of
synthetic oligonucleotides used in the studies.
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